ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants
June 18, 2021New data released today shows that Australia's Viraleze™ anti-COVID nasal spray is more than 99.9% effective against three of the four deadliest variants of the SARS-CoV-2 virus. -
Viraleze registered for sale in Covid-ravaged India
June 11, 2021India's vast population will have access from today to the Australian developed anti-COVID nasal spray Viraleze™ following its registration in the country. -
Scripps Research Institute testing shows Viraleze highly active against UK COVID strain
June 02, 2021Australia's Viraleze anti-COVID nasal spray is active against the highly infectious UK variant of SARS-CoV-2, the virus that causes COVID-19, reducing infectivity of the virus by >98%, it was announced today in a major development for the product.
Pharma Sources Insight January 2025
